Lipid-based nanocomposites for mRNA delivery: Current trends and future challenges
Journal of Composites and Compounds · 18.03.2024 · 6 (18)
DOI: 10.66224/jcc.6.1.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Composites and Compounds, online erschienen am 18.03.2024. Verfasst von Matin Sorkhabi. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Lipid nanoparticles (LNPs) are critical for the efficient delivery and intracellular transport of mRNA. They have recently been recognized as essential components of COVID-19 mRNA vaccines. Recent vaccinations have demonstrated the significant of lipid-based nanocomposite in the positive and effective delivery of mRNA therapies. These nanocomposites boost mRNA's efficacy by improving stability, biological uptake, and targeted delivery. We examine how lipid-based mRNA delivery methods are still being developed.
Zitieren
APA
Sorkhabi, M. (2024). Lipid-based nanocomposites for mRNA delivery: Current trends and future challenges. Journal of Composites and Compounds, 6(18). https://doi.org/10.66224/jcc.6.1.2
Vancouver
Sorkhabi M. Lipid-based nanocomposites for mRNA delivery: Current trends and future challenges. Journal of Composites and Compounds. 2024;6(18). doi:10.66224/jcc.6.1.2
BibTeX
@article{Sorkhabi2024,
author = {Sorkhabi, Matin},
title = {Lipid-based nanocomposites for mRNA delivery: Current trends and future challenges},
journal = {Journal of Composites and Compounds},
year = {2024},
volume = {6},
number = {18},
doi = {10.66224/jcc.6.1.2}
}
EUVIMED